V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330009601 | 330003425 | 0.92 | 42.5 | null | 2016-10-05 | 2016-10-12 | AML Interim Guidelines | N | N | 330003214 | NOT MATCHED |
| 330009602 | 330003429 | 0 | 12.3 | Palliative (P) | 2017-09-10 | 2017-12-24 | NB HRNBL-1 ch14.18/CHO(trial) +IL-2 | N | N | 330003254 | NOT MATCHED |
| 330009603 | 330003431 | null | 92.7 | Palliative (P) | null | 2017-06-18 | Cisplatin + Radiotherapy | N | N | 330003258 | CISPLATIN + RT |
| 330009604 | 330003431 | null | 14.8 | Curative (C) | 2015-12-18 | 2015-12-18 | NB HRNBL-1 COJEC Ind COURSE B | 02 | null | 330003258 | NOT MATCHED |
| 330009605 | 330003433 | 0 | 12.7 | Palliative (P) | 2013-06-16 | 2013-06-20 | NB HRNBL-1 COJEC Ind COURSE C | null | N | 330003279 | NOT MATCHED |
| 330009607 | 330007830 | 0 | 38 | null | 2015-05-17 | 2015-05-17 | EW EuroEwing 2012 Arm A VAC | N | null | 330003283 | NOT MATCHED |
| 330009608 | 330003437 | 0 | 10.25 | Curative (C) | 2017-10-15 | 2017-11-05 | null | null | null | 330003309 | NOT MATCHED |
| 330009609 | 330003437 | 0.91 | 86.05 | Adjuvant (A) | 2018-11-28 | 2018-12-14 | EMA High Dose | 2 | N | 330003309 | NOT MATCHED |
| 330009610 | 330003438 | null | 9.7 | Palliative (P) | null | 2014-05-26 | WT SIOP 2002 01 post op Carbo, Etop | N | null | 330003325 | NOT MATCHED |
| 330009611 | 330003440 | 1.62 | 7.9 | Curative (C) | 2018-11-04 | 2018-11-04 | null | Y | N | 330003327 | NOT MATCHED |
| 330009612 | 330003441 | 1.75 | 90 | Curative (C) | 2014-03-28 | 2014-03-30 | Cisplatin + Radiotherapy | N | Y | 330003329 | CISPLATIN + RT |
| 330009613 | 330003443 | null | 15.9 | Curative (C) | 2016-10-11 | 2016-10-15 | CNS LGG 2004 03 cons vinc +cyclo | 01 | N | 330003339 | NOT MATCHED |
| 330009614 | 330010263 | 0 | 41.3 | Curative (C) | 2014-09-14 | 2014-09-14 | CISPLATIN + DACTINOMYCIN + ETOPOSIDE + FILGRASTIM + METHOTREXATE | N | N | 330003346 | NOT MATCHED |
| 330009615 | 330003450 | null | null | null | 2016-01-26 | 2016-01-31 | NB HRNBL-1 COJEC Ind COURSE B | N | N | 330003348 | NOT MATCHED |
| 330009616 | 330003453 | 1.61 | null | Palliative (P) | 2015-01-20 | 2015-06-08 | EW EuroEwing 2012 Arm A VAI | N | null | 330003353 | TRIAL |
| 330009617 | 330003455 | 1.75 | 54.2 | Curative (C) | 2014-03-15 | 2014-03-15 | Doxorubicin 75mg/m2 | N | N | 330003354 | DOXORUBICIN |
| 330009618 | 330003456 | 1.82 | 68.4 | Curative (C) | null | 2017-09-26 | Cisplatin 7 day | N | null | 330003355 | CISPLATIN |
| 330009619 | 330003457 | null | 97.1 | Neo-adjuvant (N) | null | 2016-11-18 | Cisplatin | null | null | 330003375 | CISPLATIN |
| 330009620 | 330003457 | 1.83 | 84.4 | Curative (C) | null | 2016-05-04 | Doxorubicin 75mg/m2 | Y | Y | 330003375 | DOXORUBICIN |
| 330009621 | 330003459 | 0 | 32 | Curative (C) | null | 2014-12-10 | Trial Unspecified | Y | null | 330003386 | TRIAL |
| 330009622 | 330003463 | 1.51 | 58.4 | Curative (C) | 2015-10-24 | 2016-04-25 | DOXORUBICIN | N | N | 330003394 | DOXORUBICIN |
| 330009623 | 330003464 | 1.67 | null | Neo-adjuvant (N) | 2016-12-07 | 2016-12-26 | Trial Unspecified | Y | null | 330003394 | TRIAL |
| 330009624 | 330003467 | 1.81 | 73.3 | Adjuvant (A) | 2017-08-03 | 2017-08-10 | OST Mifamurtide | N | Y | 330003402 | MIFAMURTIDE |
| 330009625 | 330003470 | null | 77.75 | Curative (C) | 2014-02-05 | 2014-07-20 | Mifamurtide weeks 13-36 | 02 | N | 330003411 | MIFAMURTIDE |
| 330009626 | 330003471 | 1.57 | 65 | null | null | 2014-07-21 | METHOTREXATE | N | null | 330003438 | METHOTREXATE |
| 330009627 | 330003473 | 1.66 | 72.4 | Adjuvant (A) | null | 2013-11-21 | MIFAMURTIDE | null | null | 330003451 | MIFAMURTIDE |
| 330009629 | 330011601 | 1.79 | null | Curative (C) | null | 2014-08-22 | OST Mifamurtide | null | null | 330003453 | MIFAMURTIDE |
| 330009630 | 330011601 | 1.57 | 48.3 | Curative (C) | null | 2016-06-09 | Cisplatin | Y | null | 330003453 | CISPLATIN |
| 330009631 | 330003476 | 1.82 | 85 | Curative (C) | 2016-03-03 | 2016-03-03 | Methotrexate Intermed dose (1g/m2) | 2 | N | 330003475 | METHOTREXATE |
| 330009632 | 330003477 | 1.71 | 45.5 | Curative (C) | 2013-12-04 | 2014-02-15 | Cisplatin | N | N | 330003477 | CISPLATIN |
| 330009633 | 330003479 | null | 60.6 | Disease modification (D) | 2014-05-02 | 2017-02-01 | EW EuroEwing 2012 Arm A VAI | N | null | 330003481 | TRIAL |
| 330009634 | 330003480 | 1.59 | 64.3 | Disease modification (D) | 2014-02-15 | 2014-03-12 | Cisplatin | null | null | 330003485 | CISPLATIN |
| 330009635 | 330003481 | 1.66 | 89.5 | Neo-adjuvant (N) | null | 2014-09-08 | METHOTREXATE | null | null | 330003495 | METHOTREXATE |
| 330009636 | 330003483 | 0 | 58.5 | Neo-adjuvant (N) | 2014-07-01 | 2014-07-08 | DOXORUBICIN | N | N | 330003503 | DOXORUBICIN |
| 330009637 | 330003485 | null | 70.2 | Neo-adjuvant (N) | null | 2014-07-11 | DOXORUBICIN | null | null | 330003509 | DOXORUBICIN |
| 330009638 | 330010275 | 1.82 | 52.35 | Adjuvant (A) | 2014-04-06 | 2015-03-16 | MIFAMURTIDE | null | null | 330003518 | MIFAMURTIDE |
| 330009639 | 330003491 | 1.72 | 92.6 | null | 2017-07-22 | 2018-06-23 | DOXORUBICIN | N | N | 330003521 | DOXORUBICIN |
| 330009641 | 330007868 | 1.87 | 72.5 | Adjuvant (A) | 2013-12-29 | 2014-01-08 | EW EuroEwing 2012 Arm B IE | Y | null | 330003528 | TRIAL |
| 330009642 | 330012339 | 1.95 | 39.7 | Neo-adjuvant (N) | 2018-08-10 | 2018-08-10 | OST Euramos 1 Closed Trial - A | N | N | 330003531 | DOXORUBICIN |
| 330009643 | 330003495 | 1.8 | 88 | Curative (C) | 2013-11-13 | 2013-11-16 | Trial Unspecified | N | N | 330003536 | TRIAL |
| 330009644 | 330003498 | 1.73 | 54.9 | Neo-adjuvant (N) | 2016-09-27 | 2017-01-03 | METHOTREXATE | N | null | 330003565 | METHOTREXATE |
| 330009645 | 330003500 | 1.82 | null | Adjuvant (A) | 2016-12-09 | 2016-12-09 | MIFAMURTIDE | null | null | 330003568 | MIFAMURTIDE |
| 330009646 | 330003501 | 0 | 25.4 | Curative (C) | null | 2016-04-27 | Cisplatin 7 day | N | null | 330003572 | CISPLATIN |
| 330009647 | 330003501 | null | null | Palliative (P) | 2014-07-21 | 2014-08-02 | EW EuroEwing 2012 Arm A VAI | Y | Y | 330003572 | TRIAL |
| 330009648 | 330003507 | null | null | Adjuvant (A) | null | 2013-09-08 | Doxorubicin 75mg/m2 | N | null | 330003597 | DOXORUBICIN |
| 330009649 | 330003509 | 0 | 50.3 | Neo-adjuvant (N) | 2013-10-13 | 2013-10-22 | EW EuroEwing 2012 Arm B IE | N | N | 330003608 | TRIAL |
| 330009650 | 330003510 | 1.6 | null | Neo-adjuvant (N) | 2015-06-26 | 2015-06-26 | DOXORUBICIN | N | N | 330003619 | DOXORUBICIN |
| 330009651 | 330003511 | null | 56.8 | Curative (C) | 2017-06-21 | 2017-07-19 | Cisplatin | null | null | 330003634 | CISPLATIN |
| 330009652 | 330003512 | 1.76 | 81 | Palliative (P) | 2015-05-22 | 2015-05-22 | DOXORUBICIN | N | N | 330003635 | DOXORUBICIN |
| 330009653 | 330003514 | 1.73 | 93 | Disease modification (D) | 2014-08-04 | 2014-09-07 | Trial Unspecified | 02 | N | 330003636 | TRIAL |